Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
Adnan Muhammad Shah
Abstract
OPINION article Front. Immunol., 19 May 2020Sec. Viral Immunology Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.01021
Topics & Concepts
InflammasomeCoronavirus disease 2019 (COVID-19)CoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyDrugDrug repositioningMedicineChemistryPharmacologyInflammationImmunologyOutbreakInfectious disease (medical specialty)PathologyDiseaseInflammasome and immune disordersCOVID-19 Clinical Research StudiesKawasaki Disease and Coronary Complications